Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableLooking for participantsNCT01915511
What this trial is testing

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Who this might be right for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Duke University 3,000
Not applicableLooking for participantsNCT06162884
What this trial is testing

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of California, Los Angeles 200
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Early research (Phase 1)Looking for participantsNCT06821464
What this trial is testing

A Trial of HRS-9813 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 60
Large-scale testing (Phase 3)Looking for participantsNCT05828953
What this trial is testing

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Who this might be right for
Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University 30
Large-scale testing (Phase 3)Looking for participantsNCT06238622
What this trial is testing

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 1,700
Early research (Phase 1)Active Not RecruitingNCT04262167
What this trial is testing

Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease
University of North Carolina, Chapel Hill 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05241275
What this trial is testing

Xenon MRI and Progressive ILD

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Duke University 60
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Not applicableLooking for participantsNCT07332117
What this trial is testing

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 30
Not applicableUnknownNCT05455437
What this trial is testing

Monitoring and Evaluation Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Diseases
Pulmonary Care and Research Collaborative Limited 200
Not applicableStudy completedNCT06200714
What this trial is testing

A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib

Who this might be right for
Idiopathic Pulmonary FibrosisDiarrhoea
Boehringer Ingelheim 17
Not applicableStudy completedNCT05875532
What this trial is testing

Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 34,960
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Testing effectiveness (Phase 2)Looking for participantsNCT06422884
What this trial is testing

Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Fibrosing Interstitial Lung Disease
Endeavor Biomedicines, Inc. 200
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Testing effectiveness (Phase 2)Study completedNCT02594839
What this trial is testing

Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

Who this might be right for
Idiopathic Interstitial PneumoniaInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 20
Not applicableNo Longer AvailableNCT04739150
What this trial is testing

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim
Early research (Phase 1)Ended earlyNCT05644600
What this trial is testing

Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.

Who this might be right for
Healthy Subjects
AstraZeneca 18
Load More Results